首页STAR • NSE
add
Strides Pharma Science Ltd
昨日收盘价
₹945.45
当日价格范围
₹918.20 - ₹949.00
年度波幅
₹412.10 - ₹993.85
市值
863.83亿 INR
平均交易量
34.41万
市盈率
-
股息率
-
主要交易所
NSE
市场资讯
财务信息
损益表
收入
净收入
(INR) | 2024年3月info | 年同比变化 |
---|---|---|
收入 | 108.40亿 | 9.90% |
经营支出 | 48.78亿 | 21.08% |
净收入 | 1.82亿 | 290.47% |
净利润率 | 1.68 | 273.20% |
每股收益 | — | — |
息税折旧摊销前利润 | 23.51亿 | 133.44% |
有效税率 | 64.99% | — |
资产负债表
总资产
负债总额
(INR) | 2024年3月info | 年同比变化 |
---|---|---|
现金及短期投资 | 29.69亿 | -17.68% |
总资产 | 583.98亿 | -12.03% |
负债总额 | 376.80亿 | -15.62% |
权益总额 | 207.17亿 | — |
发行在外的股份 | 9179.29万 | — |
市净率 | 4.08 | — |
资产回报率 | — | — |
资本回报率 | 9.60% | — |
现金流
现金净变动
(INR) | 2024年3月info | 年同比变化 |
---|---|---|
净收入 | 1.82亿 | 290.47% |
来自运营的现金 | — | — |
投资现金 | — | — |
融资现金 | — | — |
现金净变动 | — | — |
自由现金流 | — | — |
简介
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore in southern India. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. Its softgel manufacturing capability consists of an annual capacity of 50,000 machine hours or about three billion softgel capsules. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. In the United States and Canadian markets, the company partners with generic companies to supply retail and hospital generics in injectable products and softgels. In European markets, it has long-term relationships for the development of projects and supply agreements with the European companies. In Australia and New Zealand, the company is engaged in manufacturing and supply of soft gels and value-added manufacturing. The company has development and supply agreements with South African companies. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India. Wikipedia
成立时间
1990
员工数量
2,850